|
Volumn 38, Issue 2, 2013, Pages 93-96
|
Quetiapine reduces irritability and risk of suicide in patients with agitated depression
|
Author keywords
Agitated depression; Irritability; Major depression; Quetiapine; Risk of suicide
|
Indexed keywords
ETHYL LOFLAZEPATE;
LORAZEPAM;
QUETIAPINE;
RAMELTEON;
SEROTONIN UPTAKE INHIBITOR;
TRICYCLIC ANTIDEPRESSANT AGENT;
ACUTE STRESS;
ADULT;
AGITATED DEPRESSION;
ANOREXIA;
ANXIETY DISORDER;
ARTICLE;
AUDITORY HALLUCINATION;
CASE REPORT;
CLINICAL FEATURE;
CONCENTRATION LOSS;
DEPRESSION;
DISEASE COURSE;
DISTRESS SYNDROME;
DRUG DOSE INCREASE;
DRUG EFFICACY;
FEMALE;
FRUSTRATION;
HAND TREMOR;
HUMAN;
INSOMNIA;
IRRITABILITY;
MAJOR DEPRESSION;
MOOD DISORDER;
NEUROLOGIC EXAMINATION;
RESTLESSNESS;
RISK REDUCTION;
SLEEP DISORDER;
SOMATIZATION;
SUICIDAL IDEATION;
TREATMENT DURATION;
TREATMENT RESPONSE;
WEIGHT REDUCTION;
ANTIPSYCHOTIC AGENTS;
ANXIETY;
DEPRESSION;
DIBENZOTHIAZEPINES;
DRUG THERAPY, COMBINATION;
FEMALE;
HUMANS;
LORAZEPAM;
MIDDLE AGED;
PSYCHOMOTOR AGITATION;
REMISSION INDUCTION;
RISK;
STRESS, PSYCHOLOGICAL;
SUICIDE, ATTEMPTED;
TREATMENT OUTCOME;
|
EID: 84880055733
PISSN: 03850005
EISSN: 21852243
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (11)
|
References (7)
|